Progyny, Inc. PGNY
Nasdaq · stock · Services-Misc Health & Allied Services, NEC · website · IPO 2019-10-25
Progyny, Inc. financials (annual)
Bars are annual figures from 2018 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $1.3B | $1.2B | $1.1B | $786.9M | $500.6M | $344.9M | $229.7M | $105.4M |
| Gross profit | $304.5M | $253.4M | $238.8M | $167.3M | $112.1M | $70.1M | $45.5M | $19.4M |
| R&D expense | $9.5M | — | — | — | — | — | — | — |
| Operating income | $85.3M | $67.5M | $62.2M | $23.3M | $32.3M | $8.3M | $9.7M | -$3.5M |
| Income tax | $36.9M | $28.9M | $8.7M | -$5.9M | -$33.3M | -$37.8M | $12,000 | -$1.8M |
| Net income | $58.5M | $54.3M | $62.0M | $30.4M | $65.8M | $46.5M | -$8.6M | $661,000 |
| EPS (diluted) | $0.65 | $0.57 | $0.62 | $0.30 | $0.66 | $0.47 | $-0.41 | $0.04 |
| Operating cash flow | $210.2M | $179.1M | $188.8M | $80.4M | $26.0M | $36.2M | -$1.5M | $2.3M |
| Free cash flow | $191.8M | $173.7M | $185.2M | $77.2M | $23.9M | $35.2M | -$4.5M | $1.7M |
| Cash & equivalents | $112.2M | $162.3M | $97.3M | $120.1M | $91.4M | $70.3M | $80.4M | $127,000 |
| Total assets | $742.4M | $607.1M | $756.6M | $543.0M | $358.1M | $253.9M | $150.4M | $41.3M |
| Total liabilities | $226.4M | $185.0M | $203.2M | $166.0M | $106.2M | $87.0M | $36.2M | $30.2M |
| Shareholders' equity | $516.0M | $422.1M | $553.4M | $377.0M | $251.8M | $166.9M | $114.3M | -$95.1M |
Growth · year-over-year · Revenue CAGR 43%
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Revenue growth | +10.4% | +7.2% | +38.3% | +57.2% | +45.2% | +50.1% | +117.9% | — |
| Net income growth | +7.7% | -12.4% | +104.4% | -53.8% | +41.6% | — | -1396.4% | — |
| EPS growth | +14.0% | -8.1% | +106.7% | -54.5% | +40.4% | — | -1125.0% | — |
| Free cash flow growth | +10.4% | -6.2% | +140.0% | +222.7% | -32.0% | — | -365.2% | — |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.